Trending

Otezla

BMS will shed Otezla to push Celgene takeover through

BMS will shed Otezla to push Celgene takeover through

Bristol-Myers Squibb has opted to divest big-selling psoriasis drug Otezla to smooth the passage of its $74 billion

X

BMS will shed Otezla to push Celgene takeover through

https://pharmaphorum.com/news/bms-will-shed-otezla-to-push-celgene-takeover-through/

Otezla gains NICE approval for psoriatic arthritis

Otezla gains NICE approval for psoriatic arthritis

Earlier decision to reject drug reversed.

X

Otezla gains NICE approval for psoriatic arthritis

https://pharmaphorum.com/news/otezla-gains-nice-approval-psoriatic-arthritis/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com